title: The first study published?
authors.affiliation: Department of Clinical Pharmacy and Toxicology, Orbis Medical Center, Sittard br.vanoijen@orbisconcern.nl.
authors.forename: B P C
authors.initials: BP
authors.lastname: van Oijen
authors.affiliation: Department of Haematology and Oncology, Orbis Medical Center, Sittard.
authors.forename: F L G
authors.initials: FL
authors.lastname: Erdkamp
authors.affiliation: Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands.
authors.forename: H C
authors.initials: HC
authors.lastname: Schouten
authors.affiliation: Department of Clinical Pharmacy and Toxicology, Orbis Medical Center, Sittard.
authors.forename: P H M
authors.initials: PH
authors.lastname: van der Kuy
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D054539:Medication Therapy Management; D009369:Neoplasms / Q000188:drug therapy*; D010607:Pharmacy Service, Hospital; D019338:Polypharmacy
chemical_list: D000970:Antineoplastic Agents